Peering Into Theriva Biologics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Theriva Biologics (NYSE:TOVX) has seen a 58.82% increase in its short percent of float, now at 0.27% of available shares. This rise in short interest suggests a bearish sentiment among investors, although it remains below the peer group average of 6.59%.
August 20, 2024 | 7:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Theriva Biologics has experienced a significant increase in short interest, rising by 58.82% to 0.27% of its float. This indicates a bearish sentiment among investors, although its short interest remains below the peer average of 6.59%.
The significant increase in short interest suggests that investors are becoming more bearish on Theriva Biologics. Although the short interest is below the peer average, the sharp rise could lead to downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100